MedPath

Impact of Aerobic Training and Combined in Inflammatory Markers in Patients With Adolescent Idiopathic Scoliosis

Not Applicable
Completed
Conditions
Scoliosis
Adolescent Scoliosis
Interventions
Other: aerobic exercise
Other: combined exercise
Device: treadmill
Registration Number
NCT02413788
Lead Sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Brief Summary

Inflammatory markers have been analyzed in several diseases of unknown etiology, in the expectation of increasing therapeutic perspectives. This possibility arises from the different levels of tissue injury with low-grade chronic inflammation that have been observed in studies in which the markers were not evaluated traditionally, and today have influenced clinical management.

The investigators aimed, therefore, to evaluate the inflammatory markers in patients with AIS before and after aerobic and combined exercise training.

Detailed Description

Inflammatory markers have not been evaluated in adolescent idiopathic scoliosis (AIS), but this deformity potentially involves various musculoskeletal structures permanently, which justifies the analysis. A low-grade chronic inflammation may be related to the lower capacity in exercise performance observed in this population, which must be stimulated to perform standardized physical activity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • thoracic curvature ≥ 45 degrees
  • indication for surgical treatment of spinal deformity
  • absence of pulmonary, cardiac, articular or neurological disorder, atopic dermatitis and previous or current allergy
  • agree part in the research with a assent statement and the person responsible with the consent form and informed
Exclusion Criteria
  • acknowledged chronic liver or kidney inflammatory disease
  • use of corticosteroids, acetylsalicylic acid or other nonhormonal anti-inflammatory clinical or laboratorial evidence of infection
  • severe obesity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
aerobic group (treadmill)aerobic exercise10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) for 36 sessions
combined group (treadmill and resisted)combined exercise- 10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) and resisted training in equipment and free weights for 10 minutes with a set of 10 repetitions in quadriceps, triceps and biceps of the arms and legs (36 sessions)
combined group (treadmill and resisted)treadmill- 10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) and resisted training in equipment and free weights for 10 minutes with a set of 10 repetitions in quadriceps, triceps and biceps of the arms and legs (36 sessions)
aerobic group (treadmill)treadmill10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) for 36 sessions
Primary Outcome Measures
NameTimeMethod
interleukin 8change from baseline in interleukin 8 at 3 months

Inflammatory Markers

interleukin 1change from baseline in interleukin 1 at 3 months

Inflammatory Markers

interleukin 6change from baseline in interleukin 6 at 3 months

Inflammatory Markers

Secondary Outcome Measures
NameTimeMethod
oxygen saturation in six-minute walk testchange from baseline in oxygen saturation at 3 months

analysis of oxygen saturation at end of test

distance in six-minute walk testchange from baseline in distance at 3 months

analysis of distance

systolic blood pressure in six-minute walk testchange from baseline in systolic blood pressure at 3 months

analysis of systolic blood pressure at end of test

heart rate in six-minute walk testchange from baseline in heart rate at 3 months

analysis of heart rate at end of test

respiratory frequency in six-minute walk testchange from baseline in respiratory frequency at 3 months

analysis of respiratory frequency at end of test

peak expiratory flowchange from baseline at 3 months

peak expiratory flow variation analysis in liters / minute (l/min)

forced vital capacity (FVC)change from baseline at 3 months

analyzed in liters or % of predicted of lung capacity variation from baseline at 3 months

FORCED EXPIRATORY FRACTION (FEF25-75%)change from baseline at 3 months

analyzed in milliliters (ml) of lung volume variation from baseline at 3 months

diastolic blood pressure in six-minute walk testchange from baseline in diastolic blood pressure at 3 months

analysis of diastolic blood pressure at end of test

forced expiratory volume in the first second (FEV1)change from baseline at 3 months

analyzed in liters or % of predicted of lung volume variation from baseline at 3 months

forced expiratory volume in the first second (FEV1) / forced vital capacity (FVC)change from baseline at 3 months

Analysis (%) of the relationship between FEV1 and FVC with variation from baseline at 3 months

Borg scale in six-minute walk testchange from baseline in Borg scale at 3 months

analysis of Borg scale at end of test

maximal inspiratory pressure (MIP)change from baseline at 3 months

analysis of maximal inspiratory pressure variation (cmH2O)

maximal expiratory pressure (MEP)change from baseline at 3 months

analysis of maximal expiratory pressure variation (cmH2O)

FORCED EXPIRATORY FRACTION (FEF25-75%) / forced vital capacity (FVC)change from baseline at 3 months

Analysis (%) of the relationship between FEV1 and FVC with variation from baseline at 3 months

Trial Locations

Locations (1)

Santa Casa of Sao Paulo Medical School

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath